<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02311153</url>
  </required_header>
  <id_info>
    <org_study_id>141421</org_study_id>
    <nct_id>NCT02311153</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery</brief_title>
  <official_title>Safety and Efficacy of Laryngeal Mask Airways in Sinonasal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Laryngeal mask airways (LMA) have been shown to be a safe mode of airway management when
      delivering general anesthesia to patients during a variety of operative procedures. LMA's
      have been studied in a wide range of otolaryngologic procedures, and are generally safe and
      accepted by both anesthesia providers and surgeons alike. This study will aim to demonstrate
      the safety and efficacy of LMA for airway management during sinonasal surgery by directly
      comparing them to endotracheal intubation in a prospective randomized single‐blind study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      LMA's have been studied in a wide range of otolaryngologic procedures, and are generally safe
      and accepted by both anesthesia providers and surgeons alike, as a safe mode of airway
      management when delivering general anesthesia. In sinonasal surgery, however, there are more
      concerns regarding the use of LMA's for airway management. Due to the nature of sinonasal
      procedures, the patient is exposed to blood and secretions that may drip/flow from the nasal
      cavity into the oropharynx and potentially into the upper and lower airways if not protected
      adequately. Additionally, often times, manipulation of the patient's head throughout the
      procedure is encountered to improve operative positioning. As a result, both surgeons and
      anesthesiologists have been hesitant to utilize LMA's in these types of surgeries despite
      documented benefits of increased patient comfort, fewer hemodynamic fluctuations during
      induction of anesthesia, and better controlled emergence when using LMA's.

      Specific Aims The overall purpose of this study is to demonstrate the ability to provide safe
      and effective ventilation and airway protection with a laryngeal mask airway (LMA) during
      sinonasal surgery, by directly comparing them to endotracheal intubation in a prospective
      randomized single‐blind study.

      Aim 1: Analyze and compare the incidence and severity of airway contamination/aspiration of
      blood and secretions during sinonasal surgery and reveal any statistically significant
      difference between LMA and endotracheal intubation.

      Aim 2: Analyze and compare the incidence of various outcome measures including laryngospasm,
      bronchospasm, anesthesia time, recovery time, post‐op pain medication requirements, and
      airway complications between LMA and endotracheal intubation.

      Aim 3: Analyze and compare both patient comfort and surgeon satisfaction after procedure
      between LMA and endotracheal intubation groups.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 25, 2014</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">July 26, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Presence or Absence of Blood/Secretions in Trachea and Larynx Based on Soiling Score</measure>
    <time_frame>intraoperative, within about 1 hour</time_frame>
    <description>Presence or absence of blood/secretions as noted in trachea and larynx. Patients were evaluated based on a soiling score completed by the surgeon, ranging from 0 (no contamination or soilage) to 3 (contamination of the tube/bloody secretions).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anesthesia Time in Minutes</measure>
    <time_frame>beginning and end of anesthesia (approximately 2 hours)</time_frame>
    <description>Start and stop time of anesthesia as recorded in anesthesia record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery Time in Minutes</measure>
    <time_frame>time spent in recovery room after surgery (approximately 4 hours)</time_frame>
    <description>Minutes spent in recovery room as recorded in the recovery room record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence of Laryngeal Spasm</measure>
    <time_frame>From start of anesthesia through hospital discharge (approximately 6 hours)</time_frame>
    <description>As recorded in anesthesia care record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-op Pain Med Requirements</measure>
    <time_frame>48 hour medicine requirement</time_frame>
    <description>Recording pain medications given to patient as noted in the recovery room records and medication administration record</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Presence or Absence of Airway Complications</measure>
    <time_frame>Start of surgery through hospital discharge (approximately 6 hours)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Conditions Requiring Sinonasal Surgery</condition>
  <arm_group>
    <arm_group_label>Endotracheal intubation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Laryngeal mask airway</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mallinckrodt Endotracheal Tube (ETT)</intervention_name>
    <description>Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
    <arm_group_label>Endotracheal intubation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Laryseal Laryngeal mask airway (LMA)</intervention_name>
    <description>Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
    <arm_group_label>Laryngeal mask airway</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (18 yo or older) undergoing elective sinonasal procedures including
             rhinoplasty, septoplasty, and paranasal sinus surgery estimated blood loss will be
             less than 300cc and the length of the procedure will be expected to last 2 hours or
             less

          -  American Society of Anesthesiologists (ASA) scores 1‐3

          -  Mallampati classification 1‐3

        Exclusion Criteria:

          -  Currently pregnant

          -  History of obstructive sleep apnea with history of difficulty with ventilation

          -  Mouth opening less than 3cm

          -  Indications for fiberoptic intubation present

          -  Upper aerodigestive tract mass or malignancy

          -  Procedure deemed emergent

          -  Severe gastroesophageal reflux, severe cardiac, pulmonary, renal or hepatic
             co‐morbidities

          -  Unable to consent to study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Justin Turner, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <study_first_submitted>November 10, 2014</study_first_submitted>
  <study_first_submitted_qc>December 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 8, 2014</study_first_posted>
  <results_first_submitted>October 31, 2017</results_first_submitted>
  <results_first_submitted_qc>May 4, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">June 1, 2018</results_first_posted>
  <last_update_submitted>May 4, 2018</last_update_submitted>
  <last_update_submitted_qc>May 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University Medical Center</investigator_affiliation>
    <investigator_full_name>Justin Turner</investigator_full_name>
    <investigator_title>Assistant Professor of Otolaryngology-Head and Neck Surgery, Assistant Professor of Biomedical Engineering</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment was completed in clinic and the pre-operative surgical area.</recruitment_details>
      <pre_assignment_details>2 patients were consented and enrolled in the clinic setting, but they did not end up being randomized:
1 did not proceed with surgery
1 was diagnosed with sleep apnea, which is exclusionary</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Endotracheal Intubation</title>
          <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
        </group>
        <group group_id="P2">
          <title>Laryngeal Mask Airway</title>
          <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="53"/>
                <participants group_id="P2" count="49"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="42"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Endotracheal Intubation</title>
          <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
        </group>
        <group group_id="B2">
          <title>Laryngeal Mask Airway</title>
          <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="53"/>
            <count group_id="B2" value="49"/>
            <count group_id="B3" value="102"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Date of birth was collected from the medical record and confirmed at date of surgery.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>Sex was recorded from the medical record, with in-person confirmation at clinic visit(s).</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="54"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="53"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Presence or Absence of Blood/Secretions in Trachea and Larynx Based on Soiling Score</title>
        <description>Presence or absence of blood/secretions as noted in trachea and larynx. Patients were evaluated based on a soiling score completed by the surgeon, ranging from 0 (no contamination or soilage) to 3 (contamination of the tube/bloody secretions).</description>
        <time_frame>intraoperative, within about 1 hour</time_frame>
        <population>Participants that started the study were analyzed. Data was missing for 1 participant in each arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Endotracheal Intubation</title>
            <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
          </group>
          <group group_id="O2">
            <title>Laryngeal Mask Airway</title>
            <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Presence or Absence of Blood/Secretions in Trachea and Larynx Based on Soiling Score</title>
          <description>Presence or absence of blood/secretions as noted in trachea and larynx. Patients were evaluated based on a soiling score completed by the surgeon, ranging from 0 (no contamination or soilage) to 3 (contamination of the tube/bloody secretions).</description>
          <population>Participants that started the study were analyzed. Data was missing for 1 participant in each arm.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Soilage score 0</title>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Soilage score 1</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Soilage score 2</title>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="10"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Soilage score 3</title>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Anesthesia Time in Minutes</title>
        <description>Start and stop time of anesthesia as recorded in anesthesia record</description>
        <time_frame>beginning and end of anesthesia (approximately 2 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Endotracheal Intubation</title>
            <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
          </group>
          <group group_id="O2">
            <title>Laryngeal Mask Airway</title>
            <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Anesthesia Time in Minutes</title>
          <description>Start and stop time of anesthesia as recorded in anesthesia record</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61" lower_limit="11" upper_limit="167"/>
                    <measurement group_id="O2" value="49" lower_limit="17" upper_limit="156"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Recovery Time in Minutes</title>
        <description>Minutes spent in recovery room as recorded in the recovery room record</description>
        <time_frame>time spent in recovery room after surgery (approximately 4 hours)</time_frame>
        <population>Participants that started the study were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Endotracheal Intubation</title>
            <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
          </group>
          <group group_id="O2">
            <title>Laryngeal Mask Airway</title>
            <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Recovery Time in Minutes</title>
          <description>Minutes spent in recovery room as recorded in the recovery room record</description>
          <population>Participants that started the study were analyzed.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>PACU phase 1 time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.5" lower_limit="7" upper_limit="111"/>
                    <measurement group_id="O2" value="30" lower_limit="5" upper_limit="112"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>PACU phase 2 time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37.5" lower_limit="2" upper_limit="181"/>
                    <measurement group_id="O2" value="40" lower_limit="0" upper_limit="220"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence of Laryngeal Spasm</title>
        <description>As recorded in anesthesia care record</description>
        <time_frame>From start of anesthesia through hospital discharge (approximately 6 hours)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Endotracheal Intubation</title>
            <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
          </group>
          <group group_id="O2">
            <title>Laryngeal Mask Airway</title>
            <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of Laryngeal Spasm</title>
          <description>As recorded in anesthesia care record</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Post-op Pain Med Requirements</title>
        <description>Recording pain medications given to patient as noted in the recovery room records and medication administration record</description>
        <time_frame>48 hour medicine requirement</time_frame>
        <population>Participants that started the study were analyzed. Data was missing for 5 participants in the Endotracheal intubation arm and 7 participants in the Laryngeal mask airway arm.</population>
        <group_list>
          <group group_id="O1">
            <title>Endotracheal Intubation</title>
            <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
          </group>
          <group group_id="O2">
            <title>Laryngeal Mask Airway</title>
            <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Post-op Pain Med Requirements</title>
          <description>Recording pain medications given to patient as noted in the recovery room records and medication administration record</description>
          <population>Participants that started the study were analyzed. Data was missing for 5 participants in the Endotracheal intubation arm and 7 participants in the Laryngeal mask airway arm.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="42"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&gt; 15 pills</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>10-14 pills</title>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>5-9 pills</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>1-4 pills</title>
                  <measurement_list>
                    <measurement group_id="O1" value="21"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No pain meds taken</title>
                  <measurement_list>
                    <measurement group_id="O1" value="22"/>
                    <measurement group_id="O2" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Presence or Absence of Airway Complications</title>
        <time_frame>Start of surgery through hospital discharge (approximately 6 hours)</time_frame>
        <population>Participants that started the study were analyzed.</population>
        <group_list>
          <group group_id="O1">
            <title>Endotracheal Intubation</title>
            <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
          </group>
          <group group_id="O2">
            <title>Laryngeal Mask Airway</title>
            <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
          </group>
        </group_list>
        <measure>
          <title>Presence or Absence of Airway Complications</title>
          <population>Participants that started the study were analyzed.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Presence of airway complications</title>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Absence of airway complicaitons</title>
                  <measurement_list>
                    <measurement group_id="O1" value="53"/>
                    <measurement group_id="O2" value="49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Patients are monitored for adverse events from the start of surgery through hospital discharge (approximately 6 hours) and are contacted again at first post-op visit, about 5 to 7 days later.</time_frame>
      <desc>Throughout the surgical procedure, the patient is monitored for any adverse events including desaturation of oxygen saturation, the occurrence of bronchospasm, laryngospasm, and other airway complications.</desc>
      <group_list>
        <group group_id="E1">
          <title>Endotracheal Intubation</title>
          <description>Endotracheal intubation for airway management and ventilation during sinonasal surgical procedure
Mallinckrodt Endotracheal Tube (ETT): Patient is intubated for airway protection and ventilation with the Mallinckrodt ETT.</description>
        </group>
        <group group_id="E2">
          <title>Laryngeal Mask Airway</title>
          <description>Laryngeal mask for airway management and ventilation during sinonasal surgical procedure
Laryseal Laryngeal mask airway (LMA): Laryseal Laryngeal mask airway is used to provide airway protection and ventilation.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="53"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="49"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Justin H. Turner, MD, PhD</name_or_title>
      <organization>Vanderbilt University Medical Center</organization>
      <email>justin.h.turner@vanderbilt.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

